课题基金 / 基金详情

DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing

DIACEST Islet Cell Capsules for Immunoprotection, MR Detection, and pH Sensing
用于免疫保护、MR 检测和 pH 传感的 DIACEST 胰岛细胞胶囊
批准号:
8023872
负责人:
MICHAEL T MCMAHON
金额:
$33.12万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-22 至 2014-08-31

项目摘要

项目成果

MICHAEL T MCMAHON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Good glycemic control is critical in reducing the end-stage complications of Type I Diabetes Mellitus (TIDM) and, for this reason, islet transplantation (ITx) has received considerable attention in recent years, with one of the complications in the treatment involves finding an effective means to prevent rejection. Immuno-isolation of islets provides a means to reduce or avoid immunosuppressive therapy altogether. In the most commonly used method of immuno-isolation, microencapsulation, individual islets are surrounded with thin alginate membranes that are permeable to insulin and metabolites, but are impermeable to native antibodies. However, the viability and in particular the insulin secretion of these islets are critical for the success of the therapy, and would be important to monitor for refinement of the treatment protocol. This proposal is focused on the production of micron sized CEST MR detectable alginate capsules containing both islet and mesenchymal stem cells which are appropriate for the treatment of T1DM. These capsules will have CEST MR contrast agents built into the capsule to allow: 1) detection, 2) discrimination between encapsulated islet and mesynchymal stem cells and 3) remote sensing of the pH of the environment. The source of the CEST contrast will be 6-24 amino acid long peptides and CEST liposomes embedded within the alginate. We will perform pre-clinical studies using a nude based mouse model of diabetes to allow monitoring of the status of encapsulated islets/ mesenchymal cells through firefly luciferase expression. PUBLIC HEALTH RELEVANCE: Islet transplantation (ITx) has received considerable attention in recent years for treatment of Type 1 Diabetes Melitus (T1DM). This proposal is focused on the production of immunoprotective islet cell capsules which are appropriate for treatment and allow MR monitoring of the pH these islets using biodegradable CEST contrast agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
Developing MRI contrast agents to detect progression in renal disease as a consequence of acidema
CEST MRI Agents for Receptor Imaging
  • 批准号:
    10226212
  • 项目类别:
  • 资助金额:
    $25.66万
  • 财政年份:
    2017
  • 负责人:
    MICHAEL T MCMAHON
  • 依托单位:
Multi-Color Exchange Transfer Imaging of Drug Delivery Nanocarriers
国内基金
海外基金
ISLET1调控小鼠牙釉质再生的分子机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2019
  • 负责人:
    张斌
  • 依托单位:
转录因子Islet-1 在糖尿病视网膜微血管病变形成中调控作用的研究
  • 批准号:
    2019JJ40507
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2019
  • 负责人:
    熊思齐
  • 依托单位:
采用CRISPR/Cas9技术探讨转录因子Islet-1调控VEGFA的表达在糖尿病视网膜病变中作用的研究
  • 批准号:
    81974137
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    熊思齐
  • 依托单位:
Islet-1诱导MSCs特化心肌细胞的电生理构建与能量代谢重塑调控
  • 批准号:
    81970244
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    朱静
  • 依托单位: